Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyethylenimine (PEI).

Barbara Demeneix1, Jean-Paul Behr

  • 1Evolution des Régulations Endocriniennes, Muséum National d'Histoire Naturelle, 7, rue Cuvier, 75231 Paris; Chimie Génétique, Faculté de Pharmacie, route du Rhin 67401 Illkirch, France.

Advances in Genetics
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure to a mixture of endocrine disrupting chemicals and thyroid function tests in pregnant women in the SELMA study.

International journal of hygiene and environmental health·2025
Same author

The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA).

Environmental health perspectives·2024
Same author

Association of endocrine disrupting chemicals exposure with human chorionic gonadotropin concentrations in pregnancy.

Environment international·2023
Same author

From Cohort to Cohort: A Similar Mixture Approach (SMACH) to Evaluate Exposures to a Mixture Leading to Thyroid-Mediated Neurodevelopmental Effects Using NHANES Data.

Toxics·2023
Same author

A Mixture of Chemicals Found in Human Amniotic Fluid Disrupts Brain Gene Expression and Behavior in <i>Xenopus laevis</i>.

International journal of molecular sciences·2023
Same author

Association of per- and polyfluoroalkyl substances with thyroid homeostasis during pregnancy in the SELMA study.

Environment international·2022
Same journal

Shaping mammalian genomes: The regulation and co-option of transposable elements in early development and gametogenesis.

Advances in genetics·2026
Same journal

Transposable elements in aging: From biomarkers to effectors.

Advances in genetics·2026
Same journal

Transposable elements in human cancer: Regulation, activation, and genomic consequences.

Advances in genetics·2026
Same journal

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

Advances in genetics·2026
Same journal

Transposable element analysis in OMICS data.

Advances in genetics·2026
Same journal

The implication of lncRNAs in the regulation of inflammation.

Advances in genetics·2026
See all related articles

Gene therapy has seen significant progress since 1999, achieving notable successes. However, challenges remain, particularly concerning the safety and efficiency of viral vectors used in treatments.

Area of Science:

  • * Biotechnology and Biomedical Sciences
  • * Molecular Biology and Genetics

Background:

  • * The field of gene therapy has experienced both remarkable advancements and persistent challenges since its inception.
  • * Early optimism for gene therapy has been tempered by the slow pace of overall progress and the need for more efficient delivery methods.
  • * Viral vectors, while instrumental in early successes, present safety concerns that continue to drive research.

Purpose of the Study:

  • * To review the progress and challenges in gene therapy research.
  • * To highlight key successes and persistent limitations in the field.
  • * To emphasize the ongoing search for improved gene delivery systems.

Main Methods:

  • * Review of seminal studies and clinical outcomes in gene therapy.

Related Experiment Videos

  • * Analysis of the efficacy and safety profiles of different gene delivery vectors.
  • * Examination of research trends and future directions in the field.

    • Main Results:

    • * Gene therapy achieved its first significant success, albeit not with the most widely researched synthetic vectors.
    • * Viral vectors, despite their utility, have demonstrated adverse effects in some applications.
    • * The development of efficient and safe gene delivery molecules remains an active area of investigation.

    Conclusions:

    • * Gene therapy holds immense promise, evidenced by critical breakthroughs.
    • * The field must address the limitations and risks associated with current viral vector technologies.
    • * Continued research into novel and safer gene delivery systems is essential for the advancement of therapeutic applications.